Lauric Haber
3PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 09, 2024
Translational findings support regimen selection for first-in-human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer.Min Zhu, Priyanka Madia, Alison Crawford
|Jun 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.Janelle C Waite, Bei Wang, Lauric Haber
|Jan 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.Dimitris Skokos, Janelle C Waite, Lauric Haber
Pageof 1
Frequent Collaborators
2 joint publications
Dimitris Skokos
2 joint publications
Janelle C Waite
2 joint publications
Alison Crawford
2 joint publications
Aynur Hermann
2 joint publications
Erica Ullman
2 joint publications
Xuan Ye
2 joint publications
Bei Wang
2 joint publications
Qi Wu
2 joint publications
Arpita Pawashe
2 joint publications
Evan Herlihy
